Dr. Hedy Kindler, M.D.
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Mesothelioma
Hedy Kindler, M.D. has run 13 trials for Mesothelioma. Some of their research focus areas include:
Pancreatic Cancer
Hedy Kindler, M.D. has run 4 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
University Of Chicago
Clinical Trials Hedy Kindler, M.D. is currently running
Pre-Surgery Immunotherapy
for Mesothelioma
This trial tests if giving immunotherapy drugs can better control disease in patients with a specific type of mesothelioma. The drugs help the immune system attack cancer cells, which may stop the cancer from growing and spreading.
Recruiting
1 award
Phase 2
27 criteria
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting
1 award
Phase 1 & 2
More about Hedy Kindler, M.D.
Clinical Trial Related
11 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Hedy Kindler, M.D. has experience with
- Pembrolizumab
- Carboplatin
- Cisplatin
- Pemetrexed
- Olaparib
- Pamrevlumab
Breakdown of trials Hedy Kindler, M.D. has run
Mesothelioma
Pancreatic Cancer
Malignant Pleural Mesothelioma
Pleural Mesothelioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hedy Kindler, M.D. specialize in?
Hedy Kindler, M.D. focuses on Mesothelioma and Pancreatic Cancer. In particular, much of their work with Mesothelioma has involved Stage IV patients, or patients who are Stage III.
Is Hedy Kindler, M.D. currently recruiting for clinical trials?
Yes, Hedy Kindler, M.D. is currently recruiting for 8 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Hedy Kindler, M.D. has studied deeply?
Yes, Hedy Kindler, M.D. has studied treatments such as Pembrolizumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Hedy Kindler, M.D.?
Apply for one of the trials that Hedy Kindler, M.D. is conducting.
What is the office address of Hedy Kindler, M.D.?
The office of Hedy Kindler, M.D. is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.